Weight loss while on the drugs can vary, with some people losing as low as five pounds to thirty pounds or higher
Effects on classic cardiovascular risk factors CVOTs on GLP-1RAs Data from the major CVOTs ELIXA, SUSTAIN-6, EXSCEL, HARMONY, PIONEER 6, LEADER, REWIND, and AMPLITUDE-O [53, 54, 56, 59,60,61,62,63] support the overall safety of GLP-1RAs relative to major cardiovascular outcomes
Lee: The most common side effects I see in practice are gastrointestinal, things like nausea, bloating, or constipation
Gallbladder disease
As a result, your strength training should begin with a lower intensity than the average person, and your progression to heavier weights should be more gradual
Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: A systematic review and meta-analysis